Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Mielke

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Blood|May 5, 2007
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host diseaseStephan Mielke, Katayoun Rezvani, Bipin N Savani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.
American Journal of Hematology|September 10, 2025
Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYuhua Ru, Jia Chen, Allain-Thibeault Ferhat, et al.
Annals of Hematology|January 30, 2021
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysisTobias Wertheimer, Marius Dohse, Gabriel Afram, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic FeaturesLeo Rasche, Christoph Röllig, Gernot Stuhler, et al.
Bone Marrow Transplantation|June 21, 2020
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT studyArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Haematologica|February 4, 2014
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemiaKate Stringaris, Takuya Sekine, Ahmad Khoder, et al.
British Journal of Haematology|May 29, 2019
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxisDenis Claude Roy, Sylvie Lachance, Sandra Cohen, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Blood|May 5, 2007
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host diseaseStephan Mielke, Katayoun Rezvani, Bipin N Savani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.
American Journal of Hematology|September 10, 2025
Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYuhua Ru, Jia Chen, Allain-Thibeault Ferhat, et al.
Annals of Hematology|January 30, 2021
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysisTobias Wertheimer, Marius Dohse, Gabriel Afram, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic FeaturesLeo Rasche, Christoph Röllig, Gernot Stuhler, et al.
Bone Marrow Transplantation|June 21, 2020
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT studyArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Haematologica|February 4, 2014
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemiaKate Stringaris, Takuya Sekine, Ahmad Khoder, et al.
British Journal of Haematology|May 29, 2019
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxisDenis Claude Roy, Sylvie Lachance, Sandra Cohen, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 13